{"id":46899,"date":"2025-11-13T16:04:06","date_gmt":"2025-11-13T08:04:06","guid":{"rendered":"https:\/\/flcube.com\/?p=46899"},"modified":"2025-11-13T16:04:07","modified_gmt":"2025-11-13T08:04:07","slug":"abbvie-to-end-11%e2%80%91year-rd-alliance-with-alphabet%e2%80%91owned-calico-labs","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46899","title":{"rendered":"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs"},"content":{"rendered":"\n<p><strong>AbbVie Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/ABBV:NYSE\">NYSE: ABBV<\/a>) announced today that it will <strong>terminate its long\u2011standing collaboration agreement<\/strong> with <strong>Calico Labs<\/strong>, the life\u2011science subsidiary of <strong>Alphabet Inc.<\/strong> The partnership, launched in 2014, focused on <strong>age\u2011related diseases and neurodegeneration<\/strong> and will wind down in accordance with the parties\u2019 termination provisions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-history-amp-financial-commitment\">Deal History &amp; Financial Commitment<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Year<\/th><th>Event<\/th><th>Total Investment Announced<\/th><\/tr><\/thead><tbody><tr><td><strong>2014<\/strong><\/td><td>Original 11\u2011year R&amp;D collaboration signed<\/td><td><strong>USD\u202f1.5\u202fbn<\/strong> (up\u2011front)<\/td><\/tr><tr><td><strong>2018<\/strong><\/td><td>First renewal<\/td><td><strong>USD\u202f0.5\u202fbn<\/strong> (AbbVie) + <strong>USD\u202f0.5\u202fbn<\/strong> (Calico)<\/td><\/tr><tr><td><strong>2021<\/strong><\/td><td>Second renewal<\/td><td><strong>USD\u202f0.5\u202fbn<\/strong> (AbbVie) + <strong>USD\u202f0.5\u202fbn<\/strong> (Calico)<\/td><\/tr><tr><td><strong>2025<\/strong><\/td><td>Termination notice filed<\/td><td>No further cash commitments<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The alliance was structured as a <strong>joint research programme<\/strong> with shared milestones, co\u2011funded laboratories, and joint intellectual\u2011property (IP) ownership.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-for-termination\">Strategic Rationale for Termination<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Portfolio realignment:<\/strong> AbbVie is refocusing capital toward its <strong>immunology, oncology, and virology pipelines<\/strong>, where near\u2011term revenue upside is clearer.<\/li>\n\n\n\n<li><strong>Milestone achievement:<\/strong> The collaboration has delivered <strong>pre\u2011clinical insights<\/strong> but has not yet produced a <strong>clinical candidate<\/strong> that meets AbbVie\u2019s go\u2011to\u2011market criteria.<\/li>\n\n\n\n<li><strong>Resource optimisation:<\/strong> Ending the partnership frees <strong>\u2248\u202fUSD\u202f200\u202fm<\/strong> of annual R&amp;D spend, allowing AbbVie to accelerate internal projects and external acquisitions.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-calico-labs\">About Calico Labs<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Founders:<\/strong> Alphabet (Google\u2019s parent) and <strong>Arthur\u202fLevinson, Ph.D.<\/strong>, former Genentech CEO and current Apple Chairman.<\/li>\n\n\n\n<li><strong>Mission:<\/strong> Translate fundamental research on <strong>aging and age\u2011related diseases<\/strong> into therapeutic pipelines.<\/li>\n\n\n\n<li><strong>Current focus:<\/strong> Early\u2011stage biology of <strong>neurodegeneration, metabolic decline, and cellular senescence<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AbbVie stock:<\/strong> Shares opened <strong>+1.3\u202f%<\/strong> on the news, reflecting investor confidence in the company\u2019s strategic pivot.<\/li>\n\n\n\n<li><strong>Alphabet stock:<\/strong> Minimal reaction; the termination is viewed as a <strong>non\u2011core biotech divestment<\/strong> for the tech conglomerate.<\/li>\n\n\n\n<li><strong>Sector outlook:<\/strong> The move underscores a broader industry trend of <strong>pharma firms trimming long\u2011duration, high\u2011risk aging programmes<\/strong> in favour of nearer\u2011term product launches.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the termination, future R&amp;D allocation, and market expectations. Actual results may differ due to regulatory outcomes, scientific progress, and macro\u2011economic conditions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AbbVie Inc. (NYSE: ABBV) announced today that it will terminate its long\u2011standing collaboration agreement with&#8230;<\/p>\n","protected":false},"author":1,"featured_media":47527,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[234,674,853],"class_list":["post-46899","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-abbvie","tag-calico-life-sciences","tag-nyse-abbv"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"AbbVie Inc. (NYSE: ABBV) announced today that it will terminate its long\u2011standing collaboration agreement with Calico Labs, the life\u2011science subsidiary of Alphabet Inc. The partnership, launched in 2014, focused on age\u2011related diseases and neurodegeneration and will wind down in accordance with the parties\u2019 termination provisions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46899\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs\" \/>\n<meta property=\"og:description\" content=\"AbbVie Inc. (NYSE: ABBV) announced today that it will terminate its long\u2011standing collaboration agreement with Calico Labs, the life\u2011science subsidiary of Alphabet Inc. The partnership, launched in 2014, focused on age\u2011related diseases and neurodegeneration and will wind down in accordance with the parties\u2019 termination provisions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46899\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-13T08:04:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T08:04:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs\",\"datePublished\":\"2025-11-13T08:04:06+00:00\",\"dateModified\":\"2025-11-13T08:04:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899\"},\"wordCount\":342,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301.webp\",\"keywords\":[\"AbbVie\",\"Calico Life Sciences\",\"NYSE: ABBV\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46899#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46899\",\"name\":\"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301.webp\",\"datePublished\":\"2025-11-13T08:04:06+00:00\",\"dateModified\":\"2025-11-13T08:04:07+00:00\",\"description\":\"AbbVie Inc. (NYSE: ABBV) announced today that it will terminate its long\u2011standing collaboration agreement with Calico Labs, the life\u2011science subsidiary of Alphabet Inc. The partnership, launched in 2014, focused on age\u2011related diseases and neurodegeneration and will wind down in accordance with the parties\u2019 termination provisions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46899\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301.webp\",\"width\":1080,\"height\":608,\"caption\":\"AbbVie to End 11\u2011Year R&D Alliance with Alphabet\u2011Owned Calico Labs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46899#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs - Insight, China&#039;s Pharmaceutical Industry","description":"AbbVie Inc. (NYSE: ABBV) announced today that it will terminate its long\u2011standing collaboration agreement with Calico Labs, the life\u2011science subsidiary of Alphabet Inc. The partnership, launched in 2014, focused on age\u2011related diseases and neurodegeneration and will wind down in accordance with the parties\u2019 termination provisions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46899","og_locale":"en_US","og_type":"article","og_title":"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs","og_description":"AbbVie Inc. (NYSE: ABBV) announced today that it will terminate its long\u2011standing collaboration agreement with Calico Labs, the life\u2011science subsidiary of Alphabet Inc. The partnership, launched in 2014, focused on age\u2011related diseases and neurodegeneration and will wind down in accordance with the parties\u2019 termination provisions.","og_url":"https:\/\/flcube.com\/?p=46899","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-13T08:04:06+00:00","article_modified_time":"2025-11-13T08:04:07+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46899#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46899"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs","datePublished":"2025-11-13T08:04:06+00:00","dateModified":"2025-11-13T08:04:07+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46899"},"wordCount":342,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46899#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301.webp","keywords":["AbbVie","Calico Life Sciences","NYSE: ABBV"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46899#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46899","url":"https:\/\/flcube.com\/?p=46899","name":"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46899#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46899#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301.webp","datePublished":"2025-11-13T08:04:06+00:00","dateModified":"2025-11-13T08:04:07+00:00","description":"AbbVie Inc. (NYSE: ABBV) announced today that it will terminate its long\u2011standing collaboration agreement with Calico Labs, the life\u2011science subsidiary of Alphabet Inc. The partnership, launched in 2014, focused on age\u2011related diseases and neurodegeneration and will wind down in accordance with the parties\u2019 termination provisions.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46899#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46899"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46899#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301.webp","width":1080,"height":608,"caption":"AbbVie to End 11\u2011Year R&D Alliance with Alphabet\u2011Owned Calico Labs"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46899#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"AbbVie to End 11\u2011Year R&amp;D Alliance with Alphabet\u2011Owned Calico Labs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46899"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46899\/revisions"}],"predecessor-version":[{"id":47526,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46899\/revisions\/47526"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/47527"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}